Brokerage house Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 845 in its research report dated August 14, 2015.

Buy Aurobindo Pharma; target of Rs 1654: Angel Broking

Angel Broking is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 1,654 in its research report dated June 9, 2015.

Large & mid-cap stocks to keep an eye on: P Lilladher

Prabhudas Lilladher has come out with its top picks report and suggested few stocks from large cap and midcap space. The research firm is revising their Nifty trading range for the market to 8200-9300 levels for the next three months while maintaining the 12 month target of 10,000, in its research report.

Angel Broking neutral on Aurobindo Pharma

Angel Broking has maintained a neutral rating on Aurobindo Pharma, in its February 10, 2015 research report.

Buy Aurobindo Pharma; target of Rs 1308: P Lilladher

Brokerage house Prabhudas Lilladher is bullish on Aurobindo Pharma and has recommended 'Buy' rating on the stock with a target price of Rs 1308, in its research report dated February 06, 2015.

Hold Aurobindo Pharma; target of Rs 1272: Sharekhan

Sharekhan has recommended a hold rating on Aurobindo Pharma with a target price of Rs 1272 per share in its research report dated February 05, 2015.

Buy Aurobindo Pharma; target of Rs 874: PLilladher

Prabhudas Lilladher is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 874 in its August 18, 2014 research report.

Buy Aurobindo Pharma; target of Rs 890: Emkay

Brokerage house Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 890 in its August 11, 2014 research report.

Angel Broking neutral on Aurobindo Pharma

Angel Broking has maintained a neutral rating on Aurobindo Pharma, in its June 04, 2014 research report.

Buy ACC; accumulate Aurobindo Pharma: Angel Broking

Angel Broking has recommended to buy ACC and accumulate Aurobindo Pharma for the target price of Rs 1225 and Rs 581 in its research reports dated February 10, 2014.

Buy Aurobindo Pharma; target of Rs 466: Ventura

Brokerage house Ventura Securities is bullish on Aurobindo Pharma and has recommended a buy rating on the stock with a target price of Rs 466 in its December 18, 2013 research report.

Buy Aurobindo Pharma; target of Rs 260: Way2Wealth

Way2Wealth is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 260, in its research report dated October 01, 2013.

Hold Aurobindo Pharma; target of Rs 195: Firstcall Research

Firstcall Research has recommended hold rating on Aurobindo Pharma with a target of Rs 195, in its September 14, 2013 report.

Buy Aurobindo Pharma; target of Rs 271: Angel Broking

Angel Broking is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 271 in its June 4, 2013 research report.

Accumulate Aurobindo Pharma; target of Rs 208: Angel

Angel Broking is bullish on Aurobindo Pharma and has recommended accumulate rating on the stock with a target of Rs 208 in its February 08, 2013 research report.

Buy Aurobindo Pharma; target Rs 247: Sharekhan

Sharekhan is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 247 in its December 20, 2012 research report.

Buy Aurobindo Pharma; target Rs 230: Emkay

Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 230 in its November 12, 2012 research report.

Buy Aurobindo Pharma; target of Rs 208: Angel Broking

Angel Broking is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 208 in its November 15, 2012 research report.

Accumulate Aurobindo Pharma; target of Rs 160: Emkay

Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended accumulate rating on the stock with a target of Rs 160 in its August 8, 2012 research report.

Buy Aurobindo Pharma; target Rs 138: Karvy Stock Broking

Karvy Stock Broking is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 138 in its February 15, 2012 research report.

Accumulate Aurobindo Pharma; target Rs 139: Emkay

Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended accumulate rating on the stock with a target price of Rs 139 in its February 14, 2012 research report.

Buy Aurobindo Pharma; target Rs 166: Angel Broking

Angel Broking is bullish on Aurobindo Pharma (APL) and has recommended buy rating on the stock with a target price of Rs 166 in its November 16, 2011 research report.

Buy Aurobindo Pharma; target of Rs 257: ICICIdirect.com

ICICIdirect.com is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 257 in its May 11, 2011 research report.

Buy Aurobindo Pharma; target of Rs 230: Unicon Investment

Unicon Investment is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 230 in its May 10, 2011 research report.

Buy Aurobindo Pharma; target of Rs 265: Emkay

Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 265 in its May 9, 2011 research report.